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This prospective, randomized, double-blinded study was
performed to evaluate the effects of intravenous metoclopra-
mide and ranitidine on preoperative gastric contents in
outpatients receiving intravenous anesthesia for laparoscopic
gynecologic surgery. Fifteen minutes before the induction of
anesthesia, the Z-M group (n = 20) received 50 mg ranitidine
and 10mg metoclopramide intravenously and the control group
(n = 20) received the same volume of normal saline. Before
the surgery, a 14-F multiorifice nasogastric tube was inserted
to aspirate the gastric contents of patients under sedation with
propofol and midazolam. The mean pH values of the gastric
fluid were 2.7 ± 2.0 (SD) [median 1.6 (range: 1.2-7.2)] in the
control group, and 6.1 ± 1.9 [median 6.8 (range 1.4-7.8)] in
the Z-M group. The mean aspirated volumes (mL) were 15.3
± 10.4 (SD) [median 11.0 (range: 5.0-44.0)] in the control
group, and 6.9 ±10.0 (SD) [median 4.5 (range: 0-38.0)] in the
Z-M group. There were significantly more high-risk (gastric
fluid volumes > 25 mL and pH< 2.5) patients in the control
group (4/20, 20%) than in the Z-M group (1/20, 5%). In
conclusion, intravenous prophylactic ranitidine and metoclo-
pramide may be an easy and useful method to decrease the
volume while increasing the pH of gastric contents, and there-
fore may reduce the number of patients at risk for aspiration
pneumonitis in ambulatory laparoscopic procedures who
receive an anesthesia.
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INTRODUCTION
Early studies suggest that outpatients may have
an increased risk of aspiration if the volume of
their gastric contents is greater than 25 mL and
the pH is less than 2.5.
1 However, Olsson et al.
found that there was no increased risk of aspira-
tion in 'fasted' outpatients compared to inpatients
undergoing elective surgery.
2 Therefore, routine
prophylaxis for aspiration is no longer recom-
mended.
3
Many outpatients receive anesthesia for surgery
by face mask or by various degrees of sedation
using intravenous anesthetics. A reduced level of
consciousness interferes with the protective upper
airway reflexes and is also associated with im-
paired function of the lower esophageal sphinc-
ter.
4,5 Pulmonary aspiration is commonly observed
in patients with impaired consciousness who were
operated on in the supine position.
6 Therefore,
outpatients undergoing laparoscopic surgery
using abdominal gas insufflations may be at risk
for acid aspiration syndrome. No reports about
the effect of intravenous pharmacotherapy on pre-
operative gastric contents in these patients have
been published.
The use of metoclopramide, a dopamine antag-
onist, in combination with an H2 receptor blocker
has been advocated to decrease postoperative
emesis and to reduce the risk of aspiration pneu-
monitis.
7 However, the time available for pre-
paration of these patients may be too short for
oral premedication to be effective because healthy
patients undergoing elective surgery may not be
seen by an anesthesiologist until the day of sur-
gery. Therefore, we have undertaken this pro-
spective, randomized, double-blinded investiga-
tion to evaluate the effects of prophylactic in-
travenous metoclopramide and ranitidine on pre-
operative gastric contents in outpatients receiving
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intravenous anesthesia for gynecologic laparo-
scopic surgery.
MATERIALS AND METHODS
The study was approved by the hospital Ethics
Committee. Written informed consent was ob-
tained from each patient. Forty women (American
Society of Anesthesiologists physical status I) un-
dergoing diagnostic laparoscopy in the infertility
clinic were enrolled. Patients with a history of any
gastrointestinal disorder or who were receiving
any medication which would interfere with gastro-
intestinal function were excluded from the study.
The study design was randomized and double-
blinded with patients allocated according to a com-
puter-generated randomization method. Fifteen
minutes before the induction of anesthesia, 50 mg
ranitidine (Zantac ; GlaxoSmithKline, Pennsylva-
nia, USA) and 10 mg metoclopramide (Mexolon ;
DongWha, Anyang, Korea) were given intrave-
nously to the Z-M group (n = 20) and the same
volume of normal saline to the control group (n =
20).
All patients fasted after midnight, and no other
premedication was given. After preoxygenation
with 100% oxygen via face mask for 5 minutes,
intravenous sedation was induced and maintained
using 0.5 mg/kg midazolam and 4 g/mL of μ
target concentration of propofol without tracheal
intubation. Before the start of surgery, a 14-F mul-
tiorifice nasogastric tube (Levin tube, Yushin
Medical, Shiheung, Korea) was inserted by an
anesthesiologist. Placement of the nasogastric tube
was verified by auscultation over the epigastrium
while injecting air and then aspirating gastric
contents. Attempts to maximize gastric fluid as-
pirate volume were made by continuing aspira-
tion intermittently as the tube was slowly with-
drawn with a rotating motion. This maneuver was
repeated in both slightly side tilting positions and
in the Trendelenburg and reverse Trendelenburg
position to ensure maximum emptying of the
stomach. The gastric aspirate was collected in an
in-line collection container, and measured later
using a graduated cylinder. All aspirations were
uneventful, and no patients experienced coughing,
laryngospasm, or vomiting during the procedure.
During the aspiration, 100% oxygen was admin-
istered intermittently with positive pressure,
when necessary. After the aspiration of gastric
contents, the nasogastric tube was removed. Anes-
thesia was maintained using increasing target
concentrations of propofol and adding incre-
mental doses of alfentanil to enhance sedation.
The volume of gastric fluid and pH were mea-
sured using a metered cylinder and a double-
checked pH meter (model-920A, Orion Research,
Inc., Beverly, Massachusetts, USA), respectively.
The blood concentration of glucose was measured
at the same time using a blood glucose meter
(SureStep, Lifescan inc. Milpitas, California, USA).
Results are given as mean ± standard deviation
(SD) or in ranges where appropriate. Statistical
analysis was performed using Mann-Whitney
rank sum test and t-test for parametric values, and
Chi-square analysis to compare the proportions of
patients in the two groups. A p < 0.05 was ac-
cepted as statistically significant. A power analysis
was performed to determine sufficient sample
sizes required for establishing significant differ-
ences in the gastric variables and in the per-
centage of patients at risk for aspiration pneu-
monia based on the results of the preliminary
study using an value of 0.05 and power of 0.9. α
RESULTS
The patients' data, preoperative diagnosis, and
procedure are presented in Table 1. There were no
statistical differences in the patients' demo-
graphics, oral fasting time, and blood glucose
concentration between the two groups.
The mean pH values of gastric fluid were 2.7 ±
2.0 (SD) [median 1.6 (range: 1.2-7.2)] in the control
group and 6.1 ± 1.9 [median 6.8 (range 1.4-7.8)] in
the Z-M group. The mean volumes aspirated (mL)
were 15.3 ± 10.4 (SD) [median 11.0 (range: 5.0-
44.0)] in the control group and 6.9 ± 10.0 (SD)
[median 4.5 (range: 0-38.0)] in the Z-M group. The
number of patients with a gastric pH below 2.5
were 13 (65%) in the control group, and 1 (5%) in
the Z-M group (p < 0.05). The number of patients
who had gastric contents greater than 25 mL were
4 (20%) in the control group, and 1 (5%) in the Z-
M group (p < 0.05). There were significantly moreMetoclopramide and Ranitidine on Gastric Contents
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patients considered high-risk for aspiration (gas-
tric fluid volumes > 25 mL and pH < 2.5) in the
control group (4/20, 20%) than in the Z-M group
(1/20, 5%).
The time taken for gastric aspiration in each
patient did not exceed 10 minutes. During the in-
sertion of the nasogastric tube, there was no epi-
staxis, vomiting, oxygen desaturation as measured
by pulse oxymeter, or any other serious compli-
cations.
DISCUSSION
Early reports investigating the potential risk of
acid aspiration pneumonitis in adult outpatients
demonstrated the presence of a gastric pH below
2.5 in 76-85% of patients, while volumes of gastric
contents greater than 25 mL were seen in 52-85%
of patients.
1,8,9 Similar to previous reports, our
data demonstrate the existence of potential risks
of acid aspiration in untreated outpatients under-
going elective surgery. 65% of our patients had a
gastric pH < 2.5 and 20% had a combination of
gastric pH < 2.5 and gastric contents volume > 25
mL. Intravenous ranitidine in combination with
metoclopramide 15 minutes before surgery signifi-
cantly reduced these risk factors. Thus, the advan-
tages and safety of intravenous ranitidine and
metoclopramide have encouraged us to use these
drugs before this type of surgery in the outpatient
anesthetic unit.
H2-receptor antagonists bind competitively to
receptors on the basal parietal cell membrane.
Metoclopramide, the most common prokinetic
drug, stimulates esophageal, gastric, and small
bowel activities. Other studies have failed to
demonstrate a significant advantage of this drug
combination over an H2 receptor antagonist alone.
However, metoclopramide may offer an addi-
tional protective effect as a result of its ability to
increase lower esophageal sphincter tone.
10
With compromised protective airway reflexes,
passive regurgitation in patients with impaired
level of consciousness may result in pulmonary
aspiration. There were 7% claims for aspiration
during regional anesthesia or sedation in the ASA
Closed Claims Project Database.
11 Therefore,
patients undergoing a laparoscopic procedure
using abdominal gas insufflation without intu-
bation must be considered to be at risk for acid
aspiration. These patients typically receive phar-
macotherapy in our hospital, although routine
administration of these drugs has not been recom-
mended by the ASA.
12 Recent guidelines by the
ASA do not recommend routine preoperative use
of gastric acid secretion blockers for patients who
have no apparent increased risk of aspiration.
There is no sufficient evidence published to
evaluate whether reduced gastric acid secretion is
associated with decreased morbidity and mor-
tality. Additional trials are needed to prove their
efficacy in decreasing the frequency of pulmonary
aspiration.
An important criticism may be directed toward
the fact that the gastric volumes in this study are
Table 1. Patients Data
Control group
(n = 20)
Z-M group
(n = 20)
Age (yr) 34.1 ± 4.5 34.0 ± 4.8
Weight (kg) 55.4 ± 6.1 56.7 ± 8.2
Height (cm) 159.6 ± 4.8 162.3 ± 6.4
Fasting time (h) 13.7 ± 1.4 13.7 ± 2.0
Glucose (mg/dL) 104.7 ± 6.5 99.3 ± 5.7
Data are mean ± SD.
Z-M group: Patients received 50 mg ranitidine and 10 mg metoclopramide intravenously fifteen minutes before the induction of
anesthesia.
There are no statistically significant differences between the two groups.Jeong-Yeon Hong
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not representative of the total volume of gastric
contents, because emptying the stomach with an
nasogastric tube has not been shown to ensure
complete emptying of gastric contents.
1 Hence, it
is possible that gastric volumes might have been
underestimated. Dye absorption technique and
fiberoptic gastroscopy are more reliable than blind
aspiration, but they are more complicated, time
consuming, and clinically limiting.
In conclusion, intravenous prophylactic raniti-
dine and metoclopramide is an easy and useful
method to decrease the volume and increase the
pH of gastric contents. Therefore, this procedure
can reduce the proportion of patients at risk of
aspiration pneumonitis who undergo laparoscopic
procedures while receiving intravenous sedation.
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